FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.65), $0.03 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $36.84 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.